Sign Out
No clinical study has been conducted in pregnant or lactating women.
Pregnancy: There are no or limited amount of clinical data on exposure to ticagrelor during pregnancy.
Animal studies do not indicate direct harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development. Ticagrelor had no effect on male or female fertility.
Because animal reproduction studies are not always predictive of a human response, ticagrelor should be used during pregnancy only if the potential benefit to the mother justifies any potential risk to the foetus.
Lactation: The use of ticagrelor during breastfeeding is not recommended because it is not known whether this medicinal product is excreted in human milk. Studies in rats have shown that ticagrelor and active metabolites are excreted in the milk.
Continue with Google